deferoxamine has been researched along with gossypol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Graier, WF; Kostner, GM; Kukovetz, WR; Simecek, S | 1 |
Bandy, B; Davison, AJ; Li, AS; Tsang, SS | 1 |
3 other study(ies) available for deferoxamine and gossypol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aorta; Bradykinin; Calcium; Cells, Cultured; Cyclic GMP; Cytochalasin B; Deferoxamine; Econazole; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Gossypol; Imidazoles; Imidazolidines; Indomethacin; Kinetics; Masoprocol; Miconazole; Nitric Oxide; Nitric Oxide Synthase; Signal Transduction; Superoxides; Swine; Time Factors | 1996 |
DNA-breaking versus DNA-protecting activity of four phenolic compounds in vitro.
Topics: Antioxidants; Ascorbic Acid; Caffeic Acids; Chelating Agents; Copper; Deferoxamine; DNA Damage; DNA, Superhelical; Electrophoresis, Agar Gel; Free Radical Scavengers; Gallic Acid; Gossypol; Hydroquinones; Iron; Mutagens; Oxidants; Oxidation-Reduction; Phenols | 2000 |